相关实验视频
Updated: Jul 27, 2025

08:02
Analysis of Cell Migration within a Three-dimensional Collagen Matrix
Published on: October 5, 2014
23.8K
IGFBP1在空间有限的迁移过程中维持细胞生存,并促进瘤转移
Guoqing Cai1, Yijun Qi2, Ping Wei3
1State Key Laboratory of Cell Biology, Shanghai Key Laboratory of Molecular Andrology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, 200031, China.
概括
胰岛素类生长因子结合蛋白1 (IGFBP1) 通过提高血管中的瘤细胞存活率来促进癌症转移. 在受限迁移中,上调的IGFBP1增强了线粒体功能,减少了活性氧物种 (ROS) 并帮助瘤扩散.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 细胞迁移对于癌症转移至关重要,涉及通过血管等狭窄空间进行导航.
- 了解支持癌细胞迁移期间生存的分子机制,对于开发抗转移疗法至关重要.
研究的目的:
- 研究胰岛素类生长因子结合蛋白1 (IGFBP1) 在癌细胞迁移和转移在封闭环境中的作用.
- 阐明IGFBP1在受限迁移期间影响细胞生存和活性氧物种 (ROS) 水平的分子途径.
主要方法:
- 在局限空间迁移期间,对瘤细胞IGFBP1表达的分析.
- 生物化学试验评估IGFBP1对AKT1介导的线粒体超氧化物失调酶 (SOD2) 酸化的作用.
- 测量线粒体ROS积累在封闭的癌细胞.
- 血液IGFBP1水平与肺癌患者转移性复发的相关性分析.
主要成果:
- 在经历空间限制迁移的瘤细胞中,IGFBP1的表达被上调.
- 分泌的IGFBP1抑制了AKT1介导的SOD2在27中的酸化,增强了SOD2的活性.
- 增强的SOD2活性减弱了线粒体ROS在受限细胞中的积累,促进了瘤细胞的存活.
- 血中IGFBP1水平升高与肺癌患者转移性复发相关.
结论:
- 通过增强线粒体ROS排毒,IGFBP1在受限迁移期间维持癌细胞存活起着重要作用.
- 这种IGFBP1介导的机制促进瘤转移,突出IGFBP1作为肺癌的潜在治疗点.
更多相关视频
相关概念视频
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Cell Migration
4.9K
Cell migration is a process by which the cells move from one location to another, playing an essential role in embryological development, repair and regeneration, immune response, and metastasis. Cells migrate in response to chemical or mechanical signals generated by specific organs or tissues. The overall mechanism includes three steps - polarization, protrusion, and release. Polarization involves the formation of a distinct cell front and rear, which determines the direction of movement.
4.9K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K

